Neil W. Gibson, Director at TCR2 THERAPEUTICS INC. (TCRR), sold 724,074 shares at $6.52 ($642K) on 2020-03-13, disclosed to the SEC on 2020-03-27.
Open-market sale of $642k TCRR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 212,560 | $0 | 0.0% |
| 2 | $0.00 | 196,177 | $0 | 0.0% |
| 3 | $0.00 | 217,974 | $0 | 0.0% |
| 4 | $6.52 | 52,000 | $339K | 52.8% |
| 5 | $6.60 | 17,723 | $117K | 18.2% |
| 6 | $6.60 | 17,723 |
| $117K |
| 18.2% |
| 7 | $6.49 | 3,009 | $20K | 3.0% |
| 8 | $6.83 | 3,120 | $21K | 3.3% |
| 9 | $7.41 | 3,140 | $23K | 3.6% |
| 10 | $7.94 | 648 | $5K | 0.8% |
| Total | $0.89 avg | 724,074 | $642K | 100% |
| Filing → |
| RGLS | SELL | 2014-10-31 | $48K | — | Filing → |
| RGLS | SELL | 2014-10-24 | $48K | — | Filing → |
| RGLS | SELL | 2014-09-15 | $34K | — | Filing → |